Excess neuromedin U keeps T cells away before aggressive neuroendocrine prostate cancer fully forms in a mouse model
Medical Xpress reports that this early T-cell exclusion creates a barrier to immunotherapy in a mouse model.
TLDR
Medical Xpress reports that excess neuromedin U keeps T cells away before aggressive neuroendocrine prostate cancer fully forms in a mouse model, creating an early barrier to immunotherapy.
Combined views
1.8K
2 Sources, first seen 4h ago
6 likes